All In MedTech

Device Trial Radar · NCT02292212

Clinical Study of Asahi ViE Dialyzer in Canada

Clinical Study of Asahi ViE Dialyzer in Canada (AVID)

Last checked: Nov 21, 2026Latest source record: Dec 11, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

17

Actual

Start

Nov 24, 2014

Primary completion

Nov 6, 2015

Study completion Nov 6, 2015

Sponsor

Lead sponsor
Asahi Kasei Medical Co., Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Nov 17, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to obtain performance data on the Asahi ViE-21 dialyzer (ViE-21) .

Conditions

  • Kidney Failure, Chronic

Interventions

  • ViE-21Device

    The subjects will be undergone three times KUF measurement sessions and three times blood sampling sessions during study period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Removal Rate of UreaTime frame: Week 1 (Pre-ViE phase), 7, 13 (ViE phase)

7 more outcomes with a free account

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.